McKinsey & Company, a global management consulting firm, has been accused of unethical practices by a former employee. The whistleblower, a former McKinsey partner, alleges that the firm has been involved in a variety of corrupt activities, including inflating prices, rigging bids, and manipulating the bankruptcy process. The firm’s business model has been described as ‘amoral’, with the pursuit of profit often taking precedence over ethical considerations.
The accusations also extend to the firm’s role in the opioid crisis. McKinsey allegedly advised Purdue Pharma on how to ‘turbocharge’ sales of OxyContin, a highly addictive opioid. This advice reportedly included tactics such as offering rebates to pharmacies based on the number of overdoses and addiction cases they could link to their OxyContin prescriptions.
The firm’s alleged actions have raised questions about the lack of regulation in the consulting industry. Critics argue that consulting firms should be held to the same ethical standards as other businesses, and that stronger regulatory oversight is needed to prevent future misconduct. McKinsey has denied any wrongdoing, but the allegations have led to calls for the firm to be held accountable for its actions.
Go to source article: https://www.thenation.com/article/society/mckinsey-whistleblower-confessions/